PBM Price Transparency and Accountability Act
Last action on Dec 4, 2025Read twice and referred to the Committee on Finance.
Take Action
Summary
If enacted, the bill would aim to increase transparency in prescription drug pricing, reduce costs for patients and taxpayers, and strengthen protections for independent pharmacies. The bill is currently under committee consideration and has not yet been voted on by the full Senate.
AI-generated summary
Lifecycle of the Bill
Introduced in Senate
Dec 4, 2025
Read twice and referred to the Committee on Finance.
Dec 4, 2025
